Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis
- 5 April 2022
- journal article
- research article
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 158, 110038
Abstract
No abstract availableKeywords
Funding Information
- Jiangnan University
This publication has 44 references indexed in Scilit:
- Escherichia coliK5 heparosan fermentation and improvement by genetic engineeringBioengineered Bugs, 2011
- Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*Journal of Biological Chemistry, 2010
- E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursorBiotechnology and Bioengineering, 2010
- Analysis of E. coli K5 capsular polysaccharide heparosanAnalytical and Bioanalytical Chemistry, 2010
- The FDA and safety—beyond the heparin crisisNature Biotechnology, 2008
- Determination of the Substrate Specificities of N-Acetyl-d-glucosaminyltransferaseBiochemistry, 2006
- The cell surface expression of group 2 capsular polysaccharides in Escherichia coli: the role of KpsD, RhsA and a multi‐protein complex at the pole of the cellMolecular Microbiology, 2005
- Synthetic biologyNature Reviews Genetics, 2005
- Overexpression of UDP-glucose dehydrogenase in Escherichia coli results in decreased biosynthesis of K5 polysaccharideBiochemical Journal, 2003
- Molecular analysis of the Escherichia coli K5 kps locus: identification and characterization of an inner‐membrane capsular polysaccharide transport systemMolecular Microbiology, 1990